Sale!

RET Gene Multiple Endocrine Neoplasia Type 2B Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RET Gene Multiple Endocrine Neoplasia Type 2B (MEN 2B) Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the RET gene, which are associated with the development of MEN 2B. This condition is a rare, hereditary cancer syndrome that predominantly affects the endocrine glands, leading to the growth of multiple neoplasms within these glands. MEN 2B is characterized by medullary thyroid carcinoma, pheochromocytomas, mucosal neuromas, and a Marfanoid habitus.

DNA Labs UAE offers this comprehensive genetic test, which is crucial for individuals with a family history of MEN 2B or those presenting symptoms related to this condition. Early detection through genetic testing can significantly influence the management and treatment strategies, potentially improving the prognosis and quality of life for affected individuals.

The cost of the RET Gene Multiple Endocrine Neoplasia Type 2B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the analysis of the RET gene for mutations that confer a high risk of MEN 2B. Given the complexity of the condition and the implications of the test results, genetic counseling is often recommended alongside testing to provide individuals and families with comprehensive support and guidance.

Description

RET Gene Multiple Endocrine Neoplasia Type 2B Genetic Test

Test Name: RET Gene Multiple Endocrine Neoplasia Type 2B Genetic Test

Components: DNA Labs UAE

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RET Gene Multiple Endocrine Neoplasia Type 2B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RET Gene Multiple Endocrine Neoplasia Type 2B NGS Genetic DNA Test gene RET

Test Details:

The RET gene is associated with multiple endocrine neoplasia type 2B (MEN2B), which is a rare genetic disorder characterized by the development of tumors in multiple endocrine glands. MEN2B is caused by mutations in the RET gene, which is involved in the growth and development of nerve cells.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the RET gene to identify any mutations or abnormalities that may be present. This type of testing allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variations.

NGS genetic testing for MEN2B can help in the diagnosis and management of the condition. It can identify individuals who carry a mutation in the RET gene, even before they develop symptoms, allowing for early intervention and surveillance.

Additionally, NGS testing can provide information about the specific mutation present, which can help guide treatment decisions and predict the risk of developing certain complications associated with MEN2B.

It is important to note that NGS testing for MEN2B should be performed by a qualified geneticist or genetic counselor, as the interpretation of the results and the implications for the individual and their family members can be complex. Genetic counseling is typically recommended before and after testing to ensure a comprehensive understanding of the results and their implications.

Test Name	RET Gene Multiple endocrine neoplasia type 2B Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cancer
Doctor	Oncologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for RET Gene Multiple endocrine neoplasia type 2B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RET Gene Multiple endocrine neoplasia type 2B NGS Genetic DNA Test gene RET
Test Details	The RET gene is associated with multiple endocrine neoplasia type 2B (MEN2B), which is a rare genetic disorder characterized by the development of tumors in multiple endocrine glands. MEN2B is caused by mutations in the RET gene, which is involved in the growth and development of nerve cells. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the RET gene to identify any mutations or abnormalities that may be present. This type of testing allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variations. NGS genetic testing for MEN2B can help in the diagnosis and management of the condition. It can identify individuals who carry a mutation in the RET gene, even before they develop symptoms, allowing for early intervention and surveillance. Additionally, NGS testing can provide information about the specific mutation present, which can help guide treatment decisions and predict the risk of developing certain complications associated with MEN2B. It is important to note that NGS testing for MEN2B should be performed by a qualified geneticist or genetic counselor, as the interpretation of the results and the implications for the individual and their family members can be complex. Genetic counseling is typically recommended before and after testing to ensure a comprehensive understanding of the results and their implications.